chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On  1/14 /21 I had the vaccine shot for Covid. on 1/19/21 I had a physical that indicated, on 1/20/21, that my white blood cell count had significantly decreased from  the prior physical . It was below the normal range.  The reading was 3.2 as compared the 7.5 on the last blood test.  I want to know... if there is a correlation between getting the vaccine shot and my much lower white blood cell count.
No further AE details; HCP called to report a TE, HCP could not confirm if vaccines have been administered or not.; This spontaneous report has been received from a healthcare professional and refers to a patient of unknown age and gender.  The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On an unspecified date in 2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, (lot number W007035, has been verified and considered valid for pre-filled syringe formulation, with an expiration date of 20-OCT-2023), hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (lot number W011266 has been verified and considered as valid for pre-filled syringe formulation, with an expiration date of 05-SEP-2024), haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection (lot number 028532 has been verified and considered as valid, with an expiration date of 09-MAY-2025), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (lot number W032494 has been verified and considered as valid, with an expiration date of expiration date of 22-NOV-2023), all administered as prophylaxis, plus sterile diluent, solution for injection/infusion, (lot number W009643 has been verified and considered as valid, with an expiration date of 14-NOV-2024). All suspect therapies were reportedly administered after having suffered a temperature excursion (product storage error). No further adverse events were reported.  This case has been considered as non-valid due to lack of patient identifiers.
About 5 minutes after vaccine was administered patient complained of feeling faint, warm, dizzy. I adjusted table so she could lean back. Mom watched her while I grabbed her an icepack. When I came back she stated she could not see. I called the doctor in the room to evaluate her, her Bp had dropped to 76/44 O2 was 100% HR was 98, called 911 patient had decreased level of consciousness responding only to painful stimuli approximately 5 minutes before coming to
2 days after receiving vaccine patient started to have paresthesias in entire L arm, from shoulder down to fingers.  No weakness or numbness.
This case was forwarded by Crucell. This initial case was received from a health professional and concerns a female patient of unspecified age who, on an unspecified date in Dec.2011, received the first dose of VIVOTIF (batch no: not reported). The patient's medical history and concomitant medications were not reported. At an unspecified time following the first dose of VIVOTIF, the patient developed an apparently non-urticarial rash on her abdomen. It was reported that the patient had decided to take the second of the four doses of VIVOTIF on 20.Dec.2011. At the time of reporting, the outcome was unknown. The event was considered non-serious.
Information has been received from a registered nurse concerning a 41 year old white female registered nurse with no known drug allergies and no birth defects or medical conditions who had a negative titer drawn on 8/21/02 during a pre-employment physical. Subsequently, on 1/30/03 and 3/3/03, the patient was vaccinated SC in the right arm with the first and second doses of varicella virus vaccine live (lot # 642635/0270M). There was no illness at the time of vaccination. There was no concomitant medication. On 5/14/04, the patient had a negative titer drawn. Unspecified medical attention was sought. There was no product quality complaint. Follow up information received from a registered nurse indicated that on 8/21/03, titer was drawn and indicated that the patient was non-immune. On 6/14/04, the patient's titer showed that the patient was immune. No further information is expected.
Pain in arm 4 hours later. 8 hours later severe headache, chills, body aches. Took 600mg Motrin & 10mg melatonin to help sleep 11 hours after injection. Woke up numerous times throughout the night with night sweats, chills, body aches, leg cramps, arm site pain.  Woke up in the morning (21 hours after injection) feeling fatigued but no other symptoms
Fainted; Nauseous; feeling a lot of pain at area; redness and hard at injection site; hard at injection site; Fatigue/feeling tired; Headache; This case was reported by a consumer via call center representative and described the occurrence of fainting in a 17-year-old male patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On 10th September 2020, the patient received Meningococcal B vaccine. On 10th September 2020, less than a day after receiving Meningococcal B vaccine, the patient experienced fainting (serious criteria GSK medically significant), nausea and injection site pain. In September 2020, the patient experienced injection site erythema, injection site induration, tiredness and headache. On an unknown date, the outcome of the fainting, headache, nausea and injection site pain were unknown and the outcome of the injection site erythema, injection site induration and tiredness were not recovered/not resolved.   It was unknown if the reporter considered the fainting, injection site erythema, injection site induration, tiredness, headache, nausea and injection site pain to be related to Meningococcal B vaccine.  Additional details were provided as follows: The reporter was patient's mother. The age at vaccination was not reported. After receiving meningococcal B vaccine, the patient fainted at the doctor's office. The patient was nauseous, then feeling a lot of pain at area. At the time of reporting, the patient still had redness and hard at injection site, feeling tired, fatigue and headache. No further details were provided.  The reporter was consented to follow up.
herpes zoster; postherpetic neuralgia; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date, the patient was inoculated with a dose of zoster vaccine live (ZOSTAVAX) (lot number, dosage and route of administration not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date (reported as "Shortly"), after receiving the zoster vaccine live (ZOSTAVAX), the patient experienced herpes zoster and postherpetic neuralgia. As a result of these symptoms, the patient was seen and treated by medical providers was still under their care. The outcome of the aforementioned events was unknown. As a result of the zoster vaccine live (ZOSTAVAX) vaccine, the patient sustained severe and permanent personal injuries. The herpes zoster and postherpetic neuralgia were considered as serious events due to they were disabling for the patient. The casuality assessment between the events and the vaccination with zoster vaccine live (ZOSTAVAX) was not provided.
Some amount leaked into his left arm; Some amount leaked into his left arm; A spontaneous report  was received from a Healthcare professional concerning a 70-year-old, male patient, who felt some amount of vaccine leaked into his left arm.  On 24 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 014M20A) in left arm for the prophylaxis of COVID-19 infection.   while administering the Moderna Covid-19 vaccine, patient felt some amount leaked into his left arm.   Action taken with mRNA-1273 in response to the events was not reported.    Outcome of the event experienced vaccine underdose which is unknown.; Reporter's Comments: This report refers to a case of Vaccine underdose AND Syringe Connection Issue of Moderna mRNA-1273,  with no associated AEs.  Causality for the medication error is not applicable.
3/11/10 Pts family reported to H.D. interpreter that client has had pain in L arm since injection, no burning, redness, lumps or fever. Encouraged visit for evaluation, unknown if she complied with request.
sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 022m20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with MEFENAMIC ACID (ADVIL [MEFENAMIC ACID]) in March 2021 for Pain in arm, at a dose of UNK dosage form. On 30-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: not provided Not provided.         Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26 May  2021 had updated address of reporter, additional information of patient, current condition of patient concomitant medication patient used to take, information regarding first dose of vaccine and vaccine facility, event outcome and stop date.
Information has been received from a physician concerning a 4 year old female who on 20-SEP-2007 was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (no lot number provided). Almost immediately after vaccination, the patient developed an area 6 to 70 cm in size with localized swelling and redness. The area was gray-looking in the center where there was swelling. The patient was treated with Benadryl and monitored for 30 minutes. The swelling went down and the patient was released. The patient was noted to be recovering. There was no product quality complaint. Additional information has been requested.
ErythemaMultiform, UrticariaPruritus, hard and itching at injection site Narrative:
Patient reports burning pain for several months and she was not able to use her arm in the workplace. Patient states that she is still not able to lift her arm over her head.
Headache / fever of 102/ joint and muscle ache and fatigue left lung pain and upper left chest pain
2-3 days after administration, patient had fever, felt burning sensation on right back, some blisters developed; mild pain. Capsaicin cream was prescribed by Dr. Patient was fine and said he did not need to use any pain med.
pt recvd vax;approx 3 mins later,collapsed;was supported by DAD;tremors noted in all  extremities lasting 30 secs; face flushed;no tremor after pt on floor;vs stable;pt did not eat breakfast;
Mom states around 7:00 pm: child had blank stare and mild reaction. Legs turned purple. Took child to ER.
Injection site red and sore about 3 wk, itchy and sore about 1 mo. Slightly itchy about 2 mo.
NO AE - vaccine error. Patient received first dose of Moderna 6/22/22 at outside facility. Patient family did not make staff aware that they already received the first dose until after they were vaccinated again today and completed their 15min waiting period. Mom reports calling 211 and the Department of Health scheduling this appointment for the family.
Patient informed Pharmacist administrator after the injection that he previously had Zostavax.  He came back into the Pharmacy in over a month later with no adverse reactions to report.
Patient escorted to recovery/treatment area, and vital signs taken. Ice pak placed on left deltoid and patient observed for an additional 20 minutes. Patient reports no further reaction. Localized area, noted to be a bit smaller on evaluation. Patient escorted to her car and reports feeling well.  Patient states she is headed to sit with her sister that had a stroke a few  months ago, advised to be alert and call  family members if she is not feeling well later on today.
Post vax, the pt developed rash on trunk, legs, and arms; blistered and scabbed over. Dx with chickenpox on 9/26/00.
ever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.  Concomitant products included METHOTREXATE SODIUM (METHOTREXATE [METHOTREXATE SODIUM]), OMEPRAZOLE, LOSARTAN POTASSIUM (LOSARTAN [LOSARTAN POTASSIUM]), ATORVASTATIN and FOLIC ACID for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) was resolving.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Around 5pm (12/28): chills, arm soreness on site of injection Trouble sleeping as sleep cycles interrupted by nightmares, also fever (101), chills and muscle/ joint aches 12/29: nausea/ vomitting  with worsening joint/muscle aches. Sent home without finishing workday. Fever continue all day and all night with syncopal episode on friday night. My husband gave me ice bath to break the fever which was 102 ( according to him). *unable to got to the bathroom unassisted from Friday afternoon and all day Saturday* 12/30: fever, muscles, joiny aches and headaches persisted but lesser in severity 12/31: first day fever free ( last and only dose of tylenol at 6am). Mild headache at time of filling up this report(8:51pm) Able to go the bathroom unassisted all day.
Arm muscle pain; This is a spontaneous report from a non-contactable consumer, the patient. An unknown gender patient of unknown age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 09:15 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date in Mar2021, the patient experienced arm muscle pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm muscle pain was unknown at the time of this report.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Felt so sick; Couldn't breath with one hole of his nose; "Reactions he never felt before"; Felt "bad bad"; Fever; Headaches; Chills; Did not received second dose; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt so sick), NASAL CONGESTION (Couldn't breath with one hole of his nose), VACCINATION COMPLICATION ("Reactions he never felt before"), FEELING ABNORMAL (Felt "bad bad") and PYREXIA (Fever) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt so sick), NASAL CONGESTION (Couldn't breath with one hole of his nose), VACCINATION COMPLICATION ("Reactions he never felt before"), FEELING ABNORMAL (Felt "bad bad"), PYREXIA (Fever), HEADACHE (Headaches), CHILLS (Chills) and PRODUCT DOSE OMISSION ISSUE (Did not received second dose). At the time of the report, MALAISE (Felt so sick), NASAL CONGESTION (Couldn't breath with one hole of his nose), VACCINATION COMPLICATION ("Reactions he never felt before"), FEELING ABNORMAL (Felt "bad bad"), PYREXIA (Fever), HEADACHE (Headaches) and CHILLS (Chills) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not received second dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No relevant concomitant medications were reported.  Treatment information included warm vitamins and Home meds.
I tested positive for COVID-19 on 2/14/23. I had a scratchy throat and thought I was getting a cold. Later that day I was unable to breathe and went to the emergency room. I was hospitalized and they ran some tests and they thought they were going to have to intubate me, but it ended up they did not. They ended up giving me remdesivir through an IV for 5 days. I was also on a steroid. After being medicated for a couple days I was very lethargic and was unable to eat. This all lasted for about a week.
Adult female who received her vaccine went to the observation area, became weak and faint. On site EMS that were stationed in the observation transported to local ER. EMS Staff consulted with the patients mother regarding reason to transport, she consented.
Lymphadenopathy or lymph node enlargement below left ear. Took ibuprofen for pain.
Rash on penis; This spontaneous case was reported by a consumer and describes the occurrence of PENILE RASH (Rash on penis) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.). Concomitant products included TRAVOPROST (TRAVATAN) for an unknown indication.    On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced PENILE RASH (Rash on penis). At the time of the report, PENILE RASH (Rash on penis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was provided.
Increasing swelling of arm starting at injection site w/pain on Monday. Pt came to pharmacy and swelling continued and still pain. Pt was instructed to see MD, advised ice, elevation and BENADRYL. R arm.
Beginning of October I had ringing in my ears. Ear lavage. Did not help. No medication and still continues
Oval 2" by 3 1/2 inch localized inflamed area on left forearm. No other symptoms.
Immunity status testing; Local reaction to immunization, initial encounter Imz - Updated meningitis #2- had redness over site after injection. Patient was monitored 20 min and ice was applied to site. No systemic sx. Asked to call if any worsening sx and will call tomorrow to check in HPV x3, Tdap 2009, MENACTRA x1, Varicella x1 at age one. Had mild case at age 5. Needs immunity testing since only one vaccine given per guidelines. F/U in 1 year for next well check.
Vaccine dose 1 3/3/2021 Lot # EN6198 Pt died from anoxic brain injury 10/19/2021
myocarditis; This literature-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (myocarditis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   LITERATURE REFERENCE: Myocarditis following immunization with mRNA COVID-19 vaccines. 2021     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced MYOCARDITIS (myocarditis) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (myocarditis) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Troponin: elevated (High) elevated.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MYOCARDITIS (myocarditis) to be possibly related.    No concomitant medication was reported. Patient received supportive care. Reportedly patient visited hospital for chest pain.  Symptoms begun few days after receiving the product.  Patient presented with acute onset of marked chest pain Infectious, ischemic, or autoimmune etiologies was not identified for myocarditis. Patient was physically fit and lacking any known history of cardiac disease, significant cardiac risk factors, or exposure to cardiotoxic agents. No structural abnormalities were noted on echocardiogram.  Company Comment: Based on the current available information and temporal association between the use of the product, and the start date of the event, a causal relationship cannot be excluded.   Author commentclinical course suggests eosinophilic hypersensitivity myocarditis as described in the context of other drug-associated and vaccine-associated myocarditis.   This case was linked to MOD-2021-284001, MOD-2021-284002, MOD-2021-284003, MOD-2021-284004, MOD-2021-284005, MOD-2021-284006, MOD-2021-245527, MOD-2021-284008, MOD-2021-284009, MOD-2021-284010, MOD-2021-284011, MOD-2021-284012, MOD-2021-284013, MOD-2021-284014, MOD-2021-284015 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Upon internal review on 08-Sep-2021 E2B Company Number was updated from US-MODERNATX, INC.-MOD-2021-245527 to US-MODERNATX, INC.- MOD-2021-284007 On 05-Jul-2021: Follow up received by safety 07-Jul-2021 included the full text article added with no new information. On 07-Jul-2021: Follow up received by safety 08-Jul-2021 included the full text article added with no new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the event, a causal relationship cannot be excluded.
Itchy, raised lump (rash) at the injection site that showed up exactly a week after the shot. ?Covid arm?
I was sick for about 2 weeks. I was put on slightly higher doses of Prednisone along with cough pearls. I had cough, sore throat, congestion, fever of 101, shortness of breath, fatigue. I still have fatigue, shortness of breath and some memory loss issues.
ADMINISTERED A DOSE OF THE VACCINE 46 MINUTES AFTER THE 6 HOUR TIME FOR HOLDING; INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 and expiry: 18-SEP-2021) dose was not reported, administered on 09-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-AUG-2021, the patient experienced administered a dose of the vaccine 46 minutes after the 6 hour time for holding. On 09-AUG-2021, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administered a dose of the vaccine 46 minutes after the 6 hour time for holding and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20210849094.
pain radiating to shoulder to hand from inject site into neck; pt called again on 18NOV w/internal burning in bronchi & wheals in bronchi; t101 for 5 days which is resolving; seen by MD who told pt was serum sickness;